This inventor holds 1 USPTO granted patent. Top assignee: Bayer Pharma Aktiengesellschaft. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Xinying Chang: Innovator in Hormonal Therapeutics
Introduction
Xinying Chang is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of hormonal therapeutics, particularly in the development of selective progesterone receptor modulators. Her work aims to address critical health issues related to sexual hormone-dependent diseases.
Latest Patents
Xinying Chang holds 1 patent for her invention titled "Selective Progesterone Receptor Modulators (SPRM) and Stabilized Estrogen Level in Patient." This patent focuses on the use of SPRMs for manufacturing pharmaceutical compositions intended for the treatment or prophylaxis of sexual hormone-dependent diseases, including endometriosis and uterine fibroids. The invention emphasizes maintaining the circulating endogenous estradiol concentration in treated women within a specific range of 40 pg/mL to 85 pg/mL.
Career Highlights
Xinying Chang is currently associated with Bayer Pharma Aktiengesellschaft, where she continues to advance her research and development efforts. Her innovative approach has positioned her as a key player in the pharmaceutical industry, particularly in the realm of women's health.
Collaborations
Throughout her career, Xinying has collaborated with notable colleagues, including Christian Seitz and Marcus-Hillert Schultze-Mosgau. These partnerships have further enriched her research and contributed to the success of her projects.
Conclusion
Xinying Chang's work in the field of hormonal therapeutics exemplifies her dedication to improving women's health through innovative solutions. Her contributions are paving the way for advancements in the treatment of hormone-dependent diseases.